Safely targeting cancer stem cells via selective catenin coactivator antagonism
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safely targeting cancer stem cells via selective catenin coactivator antagonism
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 105, Issue 9, Pages 1087-1092
Publisher
Wiley
Online
2014-06-28
DOI
10.1111/cas.12471
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia Selects for a Quiescent, CML Stem/Leukemia Initiating- Like Population Dependent on CBP/Catenin Transcription
- (2014) Aiko Kida et al. Current Molecular Pharmacology
- Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours
- (2013) Peter Wend et al. EMBO JOURNAL
- Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway
- (2013) Kaijie He et al. INTERNATIONAL JOURNAL OF CANCER
- Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia
- (2013) E J Gang et al. ONCOGENE
- The Small Molecule Wnt Signaling Modulator ICG-001 Improves Contractile Function in Chronically Infarcted Rat Myocardium
- (2013) Tomoyo Sasaki et al. PLoS One
- Functional Genomic Studies: Insights into the Pathogenesis of Liver Cancer
- (2012) Ze-Guang Han Annual Review of Genomics and Human Genetics
- On the role of Wnt/β-catenin signaling in stem cells
- (2012) Susanne J. Kühl et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Stem Cell Niche in Tissue Homeostasis, Aging and Cancer
- (2012) Shree Ram Singh CURRENT MEDICINAL CHEMISTRY
- Drugging Wnt signalling in cancer
- (2012) Paul Polakis EMBO JOURNAL
- Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability
- (2012) Y. Drier et al. GENOME RESEARCH
- Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
- (2012) Ana Chocarro-Calvo et al. MOLECULAR CELL
- The complex world of WNT receptor signalling
- (2012) Christof Niehrs NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Human Embryonic Stem Cells Differentiated to Lung Lineage-Specific Cells Ameliorate Pulmonary Fibrosis in a Xenograft Transplant Mouse Model
- (2012) Ena Ray Banerjee et al. PLoS One
- WNT secretion and signalling in human disease
- (2012) Patrick Herr et al. TRENDS IN MOLECULAR MEDICINE
- Wnt Signaling Orchestration with a Small Molecule DYRK Inhibitor Provides Long-Term Xeno-Free Human Pluripotent Cell Expansion
- (2012) Kouichi Hasegawa et al. Stem Cells Translational Medicine
- Prostaglandin E2 and Pain—An Update
- (2011) Atsufumi Kawabata BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Recapitulation of the embryonic cardiovascular progenitor cell niche
- (2011) Katja Schenke-Layland et al. BIOMATERIALS
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- Chemical ‘Jekyll and Hyde’s: small-molecule inhibitors of developmental signaling pathways
- (2011) Tomoyo Sakata et al. CHEMICAL SOCIETY REVIEWS
- The Gamma Catenin/CBP Complex Maintains Survivin Transcription in β-catenin Deficient/Depleted Cancer Cells
- (2011) Y.-M. Kim et al. CURRENT CANCER DRUG TARGETS
- Symmetric division versus asymmetric division: a tale of two coactivators
- (2011) Michael Kahn Future Medicinal Chemistry
- -catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis
- (2011) W. van Veelen et al. GUT
- Targeted Inhibition of -Catenin/CBP Signaling Ameliorates Renal Interstitial Fibrosis
- (2011) S. Hao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- β-Catenin is required for Ron receptor-induced mammary tumorigenesis
- (2011) P K Wagh et al. ONCOGENE
- Wnt/β-catenin Signaling in Embryonic Stem Cell Self-renewal and Somatic Cell Reprogramming
- (2011) Toshio Miki et al. Stem Cell Reviews and Reports
- The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators
- (2010) Jia-Ling Teo et al. ADVANCED DRUG DELIVERY REVIEWS
- mTOR Activation Induces Tumor Suppressors that Inhibit Leukemogenesis and Deplete Hematopoietic Stem Cells after Pten Deletion
- (2010) Jae Y. Lee et al. Cell Stem Cell
- Targeting Hedgehog -- a Cancer Stem Cell Pathway
- (2010) A. A. Merchant et al. CLINICAL CANCER RESEARCH
- Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
- (2010) F. Takahashi-Yanaga et al. CLINICAL CANCER RESEARCH
- Cancer Stem Cells and Self-renewal
- (2010) C. A. O'Brien et al. CLINICAL CANCER RESEARCH
- Stem cells and cancer - The promise and puzzles
- (2010) Jane E. Visvader et al. Molecular Oncology
- O2 regulates stem cells through Wnt/β-catenin signalling
- (2010) Jolly Mazumdar et al. NATURE CELL BIOLOGY
- Inhibition of Wnt/ -catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis
- (2010) W. R. Henderson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells
- (2009) Angelo Cicalese et al. CELL
- Tumour–stroma interactions in colorectal cancer: converging on β-catenin activation and cancer stemness
- (2008) N H Le et al. BRITISH JOURNAL OF CANCER
- Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways
- (2008) T. T. Onder et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Wnt Signaling Promotes Reprogramming of Somatic Cells to Pluripotency
- (2008) Alexander Marson et al. Cell Stem Cell
- Wnt signaling in ovarian tumorigenesis
- (2007) T.A. GATCLIFFE et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started